Role of Adverse Events Supervision in Clinical Trials in Neoadjuvant Treatment of Operable Stage III NSCLC
Background and objective Programmed cell death protein 1 (PD-1) combined with platinum containing dual drug chemotherapy is a new adjuvant treatment option for operable stage III non-small cell lung cancer (NSCLC), and the quality assurance of clinical trials of related drugs plays a crucial role in...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Chinês |
| Publicado: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-06-01
|
| Colección: | Chinese Journal of Lung Cancer |
| Materias: | |
| Acceso en línea: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.23 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|